Oncology Pharma Inc.
ONPH
$0.0001
$0.000.00%
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -89.72% | -81.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -89.72% | -81.24% |
| Cost of Revenue | -- | -- | -- | -91.19% | -49.34% |
| Gross Profit | -- | -- | -- | -88.89% | -103.43% |
| SG&A Expenses | -80.24% | -97.11% | -79.19% | -27.69% | -48.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -87.86% | -98.26% | -86.87% | -52.94% | -47.97% |
| Operating Income | 84.66% | 96.55% | 68.28% | -401.35% | 2.40% |
| Income Before Tax | 84.66% | 96.58% | 52.02% | -26.63% | 3.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 84.66% | 96.58% | 52.02% | -26.63% | 3.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.66% | 96.58% | 52.02% | -26.63% | 3.47% |
| EBIT | 84.66% | 96.55% | 68.28% | -401.35% | 2.40% |
| EBITDA | 88.01% | 101.23% | 71.65% | -2,664.29% | -14.71% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |